Found: 17
Select item for more details and to access through your institution.
Interferon regulatory factor 1 is essential for pathogenic CD8+ T cell migration and retention in the brain during experimental cerebral malaria.
- Published in:
- Cellular Microbiology, 2018, v. 20, n. 5, p. 1, doi. 10.1111/cmi.12819
- By:
- Publication type:
- Article
Co‐infection with Chikungunya virus alters trafficking of pathogenic CD8<sup>+</sup> T cells into the brain and prevents <italic>Plasmodium</italic>‐induced neuropathology.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 1, p. 121, doi. 10.15252/emmm.201707885
- By:
- Publication type:
- Article
Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
- Published in:
- EMBO Molecular Medicine, 2013, v. 5, n. 7, p. 916, doi. 10.1002/emmm.201202273
- By:
- Publication type:
- Article
A Plasmodium Cross-Stage Antigen Contributes to the Development of Experimental Cerebral Malaria.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.01875
- By:
- Publication type:
- Article
CD8<sup>+</sup> T Cells and IFN-γ Mediate the Time-Dependent Accumulation of Infected Red Blood Cells in Deep Organs during Experimental Cerebral Malaria.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018720
- By:
- Publication type:
- Article
Pathogenic CD8 T cells in experimental cerebral malaria.
- Published in:
- Seminars in Immunopathology, 2015, v. 37, n. 3, p. 221, doi. 10.1007/s00281-015-0476-6
- By:
- Publication type:
- Article
Author Correction: Lung endothelial cell antigen cross-presentation to CD8<sup>+</sup>T cells drives malaria-associated lung injury.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Lung endothelial cell antigen cross-presentation to CD8<sup>+</sup>T cells drives malaria-associated lung injury.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12017-8
- By:
- Publication type:
- Article
Corrigendum: Brain endothelial cells exposure to malaria parasites links type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption, and cellular metabolism.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1331366
- By:
- Publication type:
- Article
Brain endothelial cells exposure to malaria parasites links type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption, and cellular metabolism.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1149107
- By:
- Publication type:
- Article
Suppression of Plasmodium MIF-CD74 signaling protects against severe malaria.
- Published in:
- FASEB Journal, 2021, v. 35, n. 12, p. 1, doi. 10.1096/fj.202101072R
- By:
- Publication type:
- Article
Activated Brain Endothelial Cells Cross-Present Malaria Antigen.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 6, p. 1, doi. 10.1371/journal.ppat.1004963
- By:
- Publication type:
- Article
Single-Cell Transcriptome Profiling of Scale Drop Disease Virus-Infected Asian Seabass (Lates calcarifer).
- Published in:
- Aquaculture Journal, 2024, v. 4, n. 2, p. 28, doi. 10.3390/aquacj4020003
- By:
- Publication type:
- Article
Transcriptomics of rhinovirus persistence reveals sustained expression of RIG‐I and interferon‐stimulated genes in nasal epithelial cells in vitro.
- Published in:
- Allergy, 2022, v. 77, n. 9, p. 2778, doi. 10.1111/all.15280
- By:
- Publication type:
- Article
Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non‐steroidal anti‐inflammatory drug exacerbated respiratory disease.
- Published in:
- Allergy, 2022, v. 77, n. 4, p. 1297, doi. 10.1111/all.15198
- By:
- Publication type:
- Article
Measuring antigen presentation in mouse brain endothelial cells ex vivo and in vitro.
- Published in:
- Nature Protocols, 2015, v. 10, n. 12, p. 2016, doi. 10.1038/nprot.2015.129
- By:
- Publication type:
- Article
Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192717
- By:
- Publication type:
- Article